Sonic Healthcare (SHL.AX) Stock Price

Sonic Healthcare Price

ASX·CLOSED
22.58AUD+0.32 (+1.41 %)
Market closed

Revenue has compounded at 9.7% per year over the past 19 years to 9.65 B AUD. Earnings per share have grown at 3.2% per year over the last 19 years. Sonic Healthcare's net margin stands at 5.3%, down from 15.0% several years earlier. Sonic Healthcare currently offers a dividend yield of about 5.16%. The payout ratio is around 109% of earnings. The dividend has grown at 3.7% per year over the past 19 years. Analysts set a median price target of 25.47 AUD, implying 12.8% above the current price. Of 18 analysts, 8 rate the stock a buy — an overall Hold consensus. The stock trades about 23% above its 52-week low.

Sonic Healthcare stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Sonic Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sonic Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sonic Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Sonic Healthcare Stock Price History
DateSonic Healthcare Price
8/11/202622.58 AUD
8/10/202622.26 AUD
8/7/202622.25 AUD
8/6/202622.14 AUD
8/5/202622.25 AUD
8/4/202622.09 AUD
8/3/202621.70 AUD
7/31/202621.86 AUD
7/30/202622.50 AUD
7/29/202622.72 AUD
7/28/202622.01 AUD
7/27/202621.33 AUD
7/24/202621.22 AUD
7/23/202620.80 AUD
7/22/202620.80 AUD
7/21/202621.12 AUD
7/20/202621.82 AUD
7/17/202621.88 AUD
7/16/202621.74 AUD
7/15/202621.55 AUD
7/14/202621.30 AUD
7/13/202620.84 AUD
7/10/202621.19 AUD
7/9/202621.36 AUD
7/8/202621.85 AUD
7/7/202621.86 AUD
7/6/202621.54 AUD
7/3/202621.15 AUD
7/2/202620.81 AUD
7/1/202621.08 AUD
6/30/202620.80 AUD
6/29/202620.89 AUD
6/26/202620.49 AUD
6/25/202620.67 AUD
6/24/202620.03 AUD
6/23/202619.83 AUD
6/22/202619.81 AUD
6/19/202619.89 AUD
6/18/202619.75 AUD
6/17/202619.88 AUD
6/16/202619.58 AUD
6/15/202620.08 AUD
6/12/202620.19 AUD
6/11/202620.45 AUD
6/10/202620.28 AUD
6/9/202619.75 AUD
6/5/202619.28 AUD
6/4/202618.99 AUD
6/3/202618.67 AUD
6/2/202618.71 AUD
6/1/202619.07 AUD
5/29/202619.40 AUD
5/28/202618.75 AUD
5/27/202618.78 AUD
5/26/202619.06 AUD
5/25/202618.78 AUD
5/22/202618.69 AUD
5/21/202618.67 AUD
5/20/202618.55 AUD
5/19/202618.43 AUD
5/18/202618.39 AUD
5/15/202618.73 AUD
5/14/202618.51 AUD
5/13/202618.90 AUD
5/12/202618.91 AUD
5/11/202618.95 AUD
5/8/202618.94 AUD
5/7/202618.73 AUD
5/6/202618.93 AUD
5/5/202619.28 AUD
5/4/202619.97 AUD
5/1/202619.96 AUD
4/30/202619.77 AUD
4/29/202619.93 AUD
4/28/202620.18 AUD
4/27/202620.20 AUD
4/24/202620.33 AUD
4/23/202620.19 AUD
4/22/202620.08 AUD
4/21/202620.14 AUD
4/20/202620.33 AUD
4/17/202620.56 AUD
4/16/202620.53 AUD
4/15/202620.46 AUD
4/14/202620.09 AUD
4/13/202619.72 AUD
4/10/202619.77 AUD
4/9/202619.87 AUD
4/8/202620.14 AUD
4/7/202619.48 AUD
4/2/202620.01 AUD
3/27/202620.63 AUD
3/26/202620.45 AUD
3/25/202620.15 AUD
3/24/202619.65 AUD
3/23/202620.00 AUD
3/20/202620.07 AUD
3/19/202620.56 AUD
3/18/202620.81 AUD
3/17/202620.75 AUD
3/16/202620.94 AUD
3/13/202621.20 AUD
3/12/202621.11 AUD
3/11/202621.54 AUD
3/9/202621.97 AUD
3/6/202622.80 AUD
3/5/202623.27 AUD
2/26/202623.75 AUD
2/25/202623.14 AUD
2/24/202622.86 AUD
2/23/202623.02 AUD
2/20/202623.37 AUD
2/19/202623.34 AUD
2/18/202621.20 AUD
2/17/202621.43 AUD
2/16/202621.45 AUD
2/13/202621.20 AUD
2/12/202621.64 AUD
2/11/202621.97 AUD
2/10/202621.82 AUD
2/9/202622.06 AUD
2/6/202622.06 AUD
2/5/202622.64 AUD
2/4/202622.59 AUD
2/3/202622.81 AUD
2/2/202622.78 AUD
1/30/202622.89 AUD
1/29/202622.80 AUD
1/28/202622.80 AUD
1/27/202623.15 AUD
1/23/202623.34 AUD
1/21/202623.35 AUD
1/20/202623.22 AUD
1/19/202623.02 AUD
1/16/202623.21 AUD
1/14/202623.16 AUD
1/13/202623.00 AUD
1/12/202622.88 AUD
1/9/202622.36 AUD
1/8/202622.38 AUD
1/7/202622.18 AUD
1/6/202621.90 AUD
1/5/202622.26 AUD
1/2/202622.47 AUD
12/31/202522.58 AUD
12/30/202522.46 AUD
12/29/202522.65 AUD
12/24/202522.54 AUD
12/23/202522.83 AUD
12/22/202522.55 AUD
12/19/202522.58 AUD
12/18/202522.57 AUD
12/17/202522.46 AUD
12/16/202523.03 AUD
12/15/202523.09 AUD
12/12/202523.19 AUD
12/11/202523.02 AUD
12/10/202523.00 AUD
12/9/202523.26 AUD
12/8/202523.09 AUD
12/5/202523.08 AUD
12/4/202523.08 AUD
12/3/202523.08 AUD
12/2/202523.58 AUD
12/1/202523.26 AUD
11/28/202523.39 AUD
11/27/202523.36 AUD
11/26/202523.38 AUD
11/25/202523.22 AUD
11/24/202523.54 AUD
11/21/202522.99 AUD
11/20/202522.84 AUD
11/19/202521.49 AUD
11/18/202520.88 AUD
11/17/202521.01 AUD
11/14/202521.29 AUD
11/13/202521.26 AUD
11/12/202521.18 AUD
11/11/202521.09 AUD
11/10/202521.14 AUD
11/7/202520.91 AUD
11/6/202520.70 AUD
11/5/202520.69 AUD
11/4/202520.78 AUD
11/3/202520.93 AUD
10/31/202521.19 AUD
10/30/202521.05 AUD
10/29/202521.10 AUD
10/28/202521.42 AUD
10/27/202521.61 AUD
10/24/202521.75 AUD
10/23/202521.64 AUD
10/22/202521.54 AUD
10/21/202521.31 AUD
10/20/202521.58 AUD
10/17/202521.67 AUD
10/15/202521.17 AUD
10/14/202520.75 AUD
10/13/202521.05 AUD
10/10/202521.57 AUD
10/9/202521.53 AUD
10/8/202521.42 AUD
10/7/202521.74 AUD
10/6/202521.65 AUD
10/3/202521.66 AUD
10/2/202521.69 AUD
10/1/202521.32 AUD
9/30/202521.51 AUD
9/29/202521.20 AUD
9/26/202521.10 AUD
9/25/202521.50 AUD
9/24/202521.77 AUD
9/23/202522.08 AUD
9/22/202522.25 AUD
9/19/202522.41 AUD
9/18/202522.14 AUD
9/17/202522.26 AUD
9/16/202522.47 AUD
9/15/202522.46 AUD
9/12/202522.65 AUD
9/11/202522.35 AUD
9/10/202522.69 AUD
9/9/202522.71 AUD
9/8/202522.90 AUD
9/5/202522.88 AUD
9/4/202523.07 AUD
9/3/202522.70 AUD
9/2/202523.82 AUD
9/1/202524.00 AUD
8/29/202524.12 AUD
8/28/202523.99 AUD
8/27/202524.14 AUD
8/26/202524.05 AUD
8/25/202524.26 AUD
8/22/202524.96 AUD
8/21/202525.05 AUD
8/20/202528.85 AUD
8/19/202529.00 AUD
8/18/202528.55 AUD
8/15/202528.31 AUD
8/14/202528.40 AUD
8/13/202527.94 AUD
Access this data via the Eulerpool API

Sonic Healthcare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
8.17 B AUD
1.02 B AUD
684.98 M AUD
Jan 1, 2024
8.97 B AUD
849.66 M AUD
511.09 M AUD
Jan 1, 2025
9.65 B AUD
931.37 M AUD
513.60 M AUD
Jan 1, 2026 (e)
10.90 B AUD
1.68 B AUD
586.38 M AUD
Jan 1, 2027 (e)
11.18 B AUD
1.73 B AUD
626.12 M AUD
Jan 1, 2028 (e)
11.63 B AUD
1.80 B AUD
685.57 M AUD
Jan 1, 2029 (e)
12.34 B AUD
1.91 B AUD
757.04 M AUD
Jan 1, 2030 (e)
12.84 B AUD
1.63 B AUD
932.94 M AUD

Sonic Healthcare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 13, 2026, 6:50 AM
 
REVENUEB AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB AUD
EBITB AUD
EBIT MARGIN%
NET INCOMEB AUD
NET INCOME GROWTH%
DIV.AUD
DIV. GROWTH%
SHARESM
20162017201820192020202120222023202420252026e2027e2028e2029e2030e2031e
5.025.125.546.136.838.759.348.178.979.6510.9011.1811.6312.3412.8413.41
19.452.098.1810.6811.3828.156.69-12.559.787.5612.992.544.076.094.044.46
83.8383.9383.4383.7883.6581.5382.8284.3483.8183.8183.8183.8183.8183.8183.8183.81
4.214.304.625.145.717.147.746.897.528.089.139.379.7510.3410.7611.24
0.640.650.700.770.811.922.161.020.850.931.681.731.801.911.63
12.6612.5912.6012.4711.9221.9423.1312.489.479.6515.4315.4415.4315.4412.72
0.450.430.480.550.531.321.460.680.510.510.590.630.690.760.930.99
29.97-5.3211.2415.58-4.01149.5311.03-53.15-25.290.3914.236.839.4210.5123.126.33
0.840.840.900.930.961.111.431.491.061.161.291.361.44
-3.457.143.333.2315.6328.834.20-28.869.4311.215.435.88
412.93418.97423.78450.31477.16481.46482.88472.44476.99481.34481.34481.34481.34481.34481.34481.34
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Sonic Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sonic Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sonic Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Sonic Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sonic Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Sonic Healthcare stock margins

The Sonic Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sonic Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sonic Healthcare.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
81.53 %
21.95 %
15.02 %
Jan 1, 2022
82.82 %
23.13 %
15.64 %
Jan 1, 2023
84.33 %
12.48 %
8.39 %
Jan 1, 2024
83.81 %
9.47 %
5.70 %
Jan 1, 2025
83.81 %
9.66 %
5.32 %
Jan 1, 2026 (e)
83.81 %
15.44 %
5.38 %
Jan 1, 2027 (e)
83.81 %
15.44 %
5.60 %
Jan 1, 2028 (e)
83.81 %
15.44 %
5.89 %

Sonic Healthcare Stock Revenue, EBIT, Earnings per Share

The Sonic Healthcare earnings per share therefore indicates how much revenue Sonic Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
18.18 AUD
3.99 AUD
2.73 AUD
Jan 1, 2022
19.34 AUD
4.47 AUD
3.02 AUD
Jan 1, 2023
17.29 AUD
2.16 AUD
1.45 AUD
Jan 1, 2024
18.80 AUD
1.78 AUD
1.07 AUD
Jan 1, 2025
20.04 AUD
1.93 AUD
1.07 AUD
Jan 1, 2026 (e)
22.64 AUD
3.50 AUD
1.22 AUD
Jan 1, 2027 (e)
23.22 AUD
3.58 AUD
1.30 AUD
Jan 1, 2028 (e)
24.16 AUD
3.73 AUD
1.42 AUD

Sonic Healthcare business model & stock analysis

Sonic Healthcare Ltd is an Australian company that was founded in 1987 and specializes in providing medical laboratory and pathology services. The company has been listed on the Australian stock exchange since 2001 and is one of the largest medical diagnostic companies in the world. The business model of Sonic Healthcare is based on providing diagnostic services in the medical field. This includes conducting laboratory tests, pathological examinations, genetic analysis, and other diagnostic services. The company works closely with medical professionals such as doctors, hospitals, and clinics to ensure high-quality diagnostics and advice. Sonic Healthcare has various divisions that focus on specific areas of medical diagnostics. The divisions include diagnostic and radiology services in Australia, the United Kingdom, the United States, Europe, and Asia. Through this global presence, Sonic Healthcare can meet the needs of patients in different parts of the world and help improve the diagnosis and treatment of medical conditions. One of the main divisions of Sonic Healthcare is the laboratory and pathology services. The company operates laboratories in Australia, the United Kingdom, the United States, and Europe that offer a variety of clinical laboratory tests. The company also has specialized pathology laboratories that specialize in cancer diagnostics and histology, among other areas. Sonic Healthcare also offers a range of genetic diagnostics services. The genomics division specializes in exploring genetic causes of diseases and their diagnosis. The company operates specialized laboratories in Europe, Asia, and the United States that offer genetic diagnosis and counseling services. Another division of Sonic Healthcare is the radiology services. The company operates radiology practices in Australia and North America and offers a wide range of radiological examinations, including computed tomography, magnetic resonance imaging, and ultrasound. Overall, Sonic Healthcare is a diversified company that provides a variety of diagnostic services. The company specializes in medical diagnostics and works closely with medical professionals to meet the needs of patients worldwide.

Sonic Healthcare SWOT Analysis

Strengths

Sonic Healthcare Ltd has several key strengths that contribute to its success in the market:

  • Strong global presence: Sonic Healthcare operates in multiple countries worldwide, allowing it to leverage economies of scale and access diverse markets.
  • Extensive network of laboratories and clinics: The company owns and operates a vast network of diagnostic laboratories and medical clinics, providing convenient access to healthcare services.
  • Broad range of testing capabilities: Sonic Healthcare offers a wide variety of diagnostic tests, ranging from routine blood work to advanced genetic screening, catering to diverse patient needs.
  • High-quality standards: The company prioritizes accuracy and precision in its testing processes, ensuring reliable and trusted results for patients and healthcare providers.
  • Strong brand reputation: Sonic Healthcare has established a reputable brand name over the years, earning the trust and loyalty of patients, physicians, and stakeholders.

Weaknesses

Sonic Healthcare Ltd also faces certain weaknesses that may impact its performance:

  • Dependence on government healthcare policies: Changes in government regulations and funding can significantly affect the company's revenue streams, making it vulnerable to policy shifts.
  • Geographical concentration of operations: While Sonic Healthcare operates globally, a significant portion of its business is concentrated in specific regions, exposing it to localized economic downturns or disruptions.
  • Pricing pressures: The healthcare industry is subject to pricing pressures, and Sonic Healthcare faces potential challenges in maintaining profitability while pricing its services competitively.
  • Reliance on skilled workforce: The company's success heavily relies on recruiting and retaining skilled healthcare professionals, and any shortages or difficulties in attracting talent could impact its operations.

Opportunities

There are several opportunities that Sonic Healthcare Ltd can capitalize on:

  • Increasing demand for diagnostic services: As the importance of preventive healthcare grows, there is a rising demand for diagnostic testing services, providing Sonic Healthcare with potential for revenue growth.
  • Technological advancements: Advancements in technology, such as automation and digitalization, can enhance the efficiency and accuracy of Sonic Healthcare's testing processes, improving overall operational performance.
  • Expansion into emerging markets: Sonic Healthcare can explore expansion opportunities in developing markets that have yet to fully adopt advanced diagnostic services, tapping into growing populations with increasing healthcare needs.
  • Partnerships and acquisitions: Collaborating with other healthcare providers or acquiring complementary businesses can enable Sonic Healthcare to expand its service offerings, diversify its revenue streams, and gain competitive advantages.

Threats

Sonic Healthcare Ltd faces certain threats that may pose challenges to its growth and profitability:

  • Intense competition: The healthcare industry is highly competitive, and Sonic Healthcare faces competition from both established players and emerging disruptors, potentially impacting its market share.
  • Regulatory and compliance risks: Compliance with changing healthcare regulations and maintaining high-quality standards can be demanding, and non-compliance may lead to penalties, legal actions, or reputational damage.
  • Economic downturns: Sonic Healthcare's business can be sensitive to economic cycles, and recessions or financial crises can reduce patient volumes and discretionary spending on healthcare services.
  • Technological disruption: Rapid technological advancements in the healthcare industry may render certain testing methods or services obsolete, requiring Sonic Healthcare to continuously adapt and invest in new technologies.

Sonic Healthcare Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Sonic Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

Sonic Healthcare annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Sonic Healthcare shares outstanding

The number of shares of Sonic Healthcare was 481.34 M in 2025. This indicates how many shares Sonic Healthcare is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
481.46 M Stocks
Jan 1, 2022
482.88 M Stocks
Jan 1, 2023
472.44 M Stocks
Jan 1, 2024
476.99 M Stocks
Jan 1, 2025
481.34 M Stocks
Jan 1, 2026 (e)
481.34 M Stocks
Jan 1, 2027 (e)
481.34 M Stocks
Jan 1, 2028 (e)
481.34 M Stocks

Sonic Healthcare Dividend History

33 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.57AUDYTD
Mar 4, 20260.57AUD 21.9%1/1
20251.16AUD 9.9%
Mar 5, 20250.44AUD 30.2%1/2
Sep 3, 20250.72AUD 64.7%2/2
20241.06AUD 28.7%
20231.49AUD 4.0%
20221.43AUD 28.8%
20211.11AUD 15.7%
20200.96AUD 2.7%
20190.93AUD 3.7%
20180.90AUD 7.7%
20170.84AUD 0.1%

Sonic Healthcare dividend history and estimates

In 2025, Sonic Healthcare paid a dividend amounting to 1.16 AUD. Dividend means that Sonic Healthcare distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.11 AUD
0.00 AUD
Jan 1, 2022
1.43 AUD
0.00 AUD
Jan 1, 2023
1.49 AUD
0.00 AUD
Jan 1, 2024
1.06 AUD
0.00 AUD
Jan 1, 2025
1.16 AUD
0.00 AUD
Jan 1, 2026
1.29 AUD
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
1.36 AUD
Jan 1, 2028 (e)
0.00 AUD
1.44 AUD

Sonic Healthcare dividend payout ratio

In 2025, Sonic Healthcare had a payout ratio of 109.14%. The payout ratio indicates the percentage of the company's profits that Sonic Healthcare distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
40.62 %
Jan 1, 2022
47.23 %
Jan 1, 2023
102.47 %
Jan 1, 2024
98.93 %
Jan 1, 2025
109.14 %
Jan 1, 2026 (e)
105.91 %
Jan 1, 2027 (e)
104.76 %
Jan 1, 2028 (e)
101.04 %

Current Sonic Healthcare forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.89 %
Buy
44.44 % (8)
Hold
44.44 % (8)
Sell
11.11 % (2)
12M Price Target
25.47
Last Price
22.30
Currency
AUD
12M Return Potential
14.24 %
LTM Return
0 %

Sonic Healthcare Earnings Calls

Sonic Healthcare Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
2/14/20240.57AUD-4.27 BAUD-2024 Q2
8/22/20230.70AUD-3.84 BAUD-2023 Q4
2/20/20230.92AUD-4.12 BAUD-2023 Q2
8/24/20221.10AUD-4.55 BAUD-2022 Q4
2/21/20221.95AUD-5.08 BAUD-2022 Q2
8/23/20211.34AUD-4.79 BAUD-2021 Q4
2/18/20211.17AUD-4.24 BAUD-2021 Q2
8/20/20200.55AUD-3.33 BAUD-2020 Q4
2/19/20200.55AUD-3.35 BAUD-2020 Q2
8/20/20190.64AUD-3.34 BAUD-2019 Q4

EESG©

Eulerpool ESG Scorecard© for the Sonic Healthcare stock

88/100
99
Environment
99
Social
65
Governance
E

Environment

20
Scope 1 - Direct Emissions36,098
Scope 2 - Indirect emissions from purchased energy74,273
Scope 3 - Indirect emissions within the value chain358,463
Total CO₂ emissions110,371
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees72.6
Percentage of women in management
Percentage of Asian employees14
Share of Asian management
Percentage of Hispanic/Latino employees19
Hispano/Latino Management share
Percentage of Black employees20
Black Management Share
Percentage of white employees41
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Sonic Healthcare shareholder structure

% Name
5.48890%
State Street Investment Management Australia Ltd.
State Street Investment Management Australia Ltd.
2.20168%
Vanguard Investments Australia Ltd.
Vanguard Investments Australia Ltd.
1.66001%
Norges Bank Investment Management (NBIM)
Norges Bank Investment Management (NBIM)
1.29929%
State Street Investment Management (US)
State Street Investment Management (US)
1.02536%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
0.99776%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
...

Sonic Healthcare Beneficial Ownership Filings (SEC 13D/G)

Free Float
92.7%
Float Shares
-
Shares Outstanding
-

Sonic Healthcare Executives and Management Board

10 members · avg. age 67 · 50 % women

CG

Dr. Colin Goldschmidt

Chief Executive Officer, Managing Director, Executive Director · since 1993

5.16 M AUD

Management

CW

Mr. Christopher Wilks (65)

Chief Financial Officer, Finance Director, Executive Director · since 1989

2.39 M AUD
PA

Mr. Paul Alexander

Deputy Chief Financial Officer, Company Secretary

Board of Directors

PC

Prof. Mark Compton (62)

Non-Executive Independent Chairman of the Board

577,500.00 AUD
NM

Mr. Neville Mitchell (64)

Non-Executive Independent Director

279,300.00 AUD
KS

Ms. Kathryn Spargo (71)

Non-Executive Independent Director

276,150.00 AUD
PC

Prof. Suzanne Crowe (73)

Non-Executive Independent Director

265,650.00 AUD
PB

Prof. Christine Bennett

Non-Executive Independent Director

224,963.00 AUD
KG

Dr. Katharine Giles

Independent Non-Executive Director

210,000.00 AUD

Sonic Healthcare Supply Chain

Sonic Healthcare Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
7 companies
#Nameβ 1YTrend
1
BlackRock
Supplier·Customer·Capital Markets·US
0.33
-0.77
0.22
0.82
0.68
0.80
0.60
2
State Street
Supplier·Customer·Capital Markets·US
-0.02
-0.84
0.22
0.55
0.47
0.72
3
JPMorgan Chase
Supplier·Customer·Banks·US
0.24
-0.65
0.42
0.78
0.58
0.67
0.38
4
Vital Healthcare Prop Tr
Supplier·Equity Real Estate Investment Trusts (REITs)·NZ
0.58
-0.49
-0.42
-0.45
-0.07
0.42
-0.06
5
Citigroup
Supplier·Customer·Banks·US
0.19
-0.13
0.42
0.52
0.27
0.40
0.23
#Nameβ 1YTrend
1
LBT Innovations
Supplier·Health Care Equipment & Supplies·AU
0.12
0.11
0.69
0.66
0.61
-0.31
2
HSBC Holdings
Supplier·Customer·Banks·GB
0.35
-0.35
0.75
-0.55
-0.48
0.26
-0.51

Frequently asked questions about Sonic Healthcare

The business model of Sonic Healthcare Ltd revolves around providing comprehensive and high-quality medical diagnostic services. As one of the largest global pathology providers, Sonic Healthcare operates an extensive network of laboratories and healthcare facilities worldwide. The company offers an array of diagnostic tests, including pathology, radiology, molecular diagnostics, and laboratory management services. Sonic Healthcare's business model focuses on delivering accurate and timely results, enabling enhanced patient care and treatment decisions. By leveraging advanced technology and a dedicated team of healthcare professionals, Sonic Healthcare aims to improve patient outcomes and contribute to the overall advancement of healthcare services globally.

Sonic Healthcare Ltd is primarily active in the healthcare industry.

The main competitors of Sonic Healthcare Ltd in the market are LabCorp, Quest Diagnostics, and Becton, Dickinson and Company (BD).

Sonic Healthcare Ltd is a leading global medical diagnostics company. Established in 1987, Sonic Healthcare has grown to become one of the largest pathology providers worldwide. The company is headquartered in Sydney, Australia, and operates in more than 30 countries, including the United States, Germany, and the United Kingdom. Sonic Healthcare offers a comprehensive range of laboratory and radiology services, catering to both the private and public healthcare sectors. With a strong focus on innovation and technological advancements, Sonic Healthcare continues to provide accurate and timely diagnostic solutions for patient care.

Sonic Healthcare Ltd has achieved significant milestones throughout its history. The company, which is a leading provider of laboratory and diagnostic services globally, has consistently expanded its operations and enhanced its offerings. With a strong focus on innovation and technology, Sonic Healthcare has successfully implemented advanced diagnostic techniques and state-of-the-art laboratory equipment. Additionally, the company has established strategic partnerships and acquisitions, further strengthening its market position. Sonic Healthcare's commitment to delivering high-quality healthcare services has earned it recognition and trust from patients and medical professionals worldwide. Through continuous growth and advancements, Sonic Healthcare Ltd has solidified its reputation as a premier provider in the field of healthcare diagnostics.

Sonic Healthcare Ltd is primarily present in various countries and regions around the world. With operations in Australia, the United States, Germany, the United Kingdom, Switzerland, Belgium, New Zealand, and Ireland, Sonic Healthcare has established a global presence in the healthcare industry. Through its extensive network of clinical laboratories and diagnostic services, the company serves patients and healthcare providers in these locations, delivering high-quality healthcare solutions. Sonic Healthcare Ltd's widespread international presence allows it to leverage its expertise and resources across different markets, contributing to its success as a leading provider of laboratory medicine and pathology services.

Sonic Healthcare Ltd represents values of excellence, integrity, and innovation in the healthcare industry. As a leading global provider of diagnostic services, Sonic Healthcare is committed to delivering the highest quality of patient care and accurate medical testing. The company's corporate philosophy revolves around maintaining strong relationships with healthcare professionals, investing in advanced technologies, and continuously improving healthcare outcomes. Sonic Healthcare's dedication to accuracy, reliability, and ethical practices has positioned it as a trusted partner for healthcare organizations worldwide. With a focus on superior patient care and continuous advancement, Sonic Healthcare Ltd remains at the forefront of the healthcare sector.

Analysts currently set an average price target of 26.14 AUD for the Sonic Healthcare stock (median: 25.47 AUD), implying +17.2 % versus the latest price. The consensus is based on 18 analyst ratings.

18 analysts currently rate the Sonic Healthcare stock: 8 recommend buying, 8 holding and 2 selling. For 2026, analysts expect Sonic Healthcare to generate revenue of 10.90 B AUD and earnings per share of 1.22 AUD.

Converted at the current exchange rate, the Sonic Healthcare share trades at 13.83 EUR (22.58 AUD).

The Sonic Healthcare share (SHL.AX) is listed on 7 stock exchanges, including: Frankfurt (SAB.F), München (SAB.MU), Düsseldorf (SAB.DU), Hamburg (SAB.HM), SIX (Zürich) (SHL1.SW), ASX (SHL.AX).

Sonic Healthcare Ltd is an Australian company that offers laboratory services in various healthcare industries. The company currently operates over 270 labs in 8 countries, including Australia, Europe, Asia, and North America. The company provides a wide range of laboratory services, including diagnostic tests, pathology, oncology, reproductive health, as well as forensic and environmental testing. Sonic also operates medical centers and hospitals and offers telemedicine services. With a strong presence in Australia and Europe, Sonic Healthcare Ltd is the largest medical diagnostics company in Australia and the third largest in Europe. The company also offers its services in North America, where Sonic Healthcare Ltd is represented in over 20 states. Sonic Healthcare Ltd aims to provide top-quality, cost-effective healthcare services by utilizing innovative technologies and state-of-the-art diagnostic techniques. The company has invested in new technologies, such as artificial intelligence, in recent years to improve the efficiency and accuracy of its diagnostic tests. Sonic Healthcare Ltd also offers specialized services in the fields of oncology and reproductive health. These include genetic testing, prostate cancer diagnostics, breast cancer screening, and fertility testing. The company works closely with medical professionals to offer these patients specialized and personalized services. In 2020, the company achieved a revenue of 7.8 billion AUD and employed 36,000 employees. Sonic Healthcare Ltd has a highly diversified customer base and collaborates with various healthcare facilities, private hospitals, and public health authorities. With a strong global presence and its laboratory services in various healthcare sectors, Sonic Healthcare Ltd is well-positioned. The company aims to provide top-quality, cost-effective services and to utilize the latest technologies and diagnostic techniques to improve performance. In a market characterized by consolidation and high competitive pressure, Sonic Healthcare Ltd will continue to grow and focus on innovative technologies and customer-oriented services to maintain its position as one of the leading providers of laboratory services in the healthcare industry.

The expected revenue of Sonic Healthcare is 10.90 B AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Sonic Healthcare is 586.38 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Sonic Healthcare is currently 18.53. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sonic Healthcare stock.

The price-to-sales ratio (P/S) of Sonic Healthcare is currently 1.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sonic Healthcare stock.

The Eulerpool Quality Score for Sonic Healthcare is 4/10.

The ISIN of Sonic Healthcare is AU000000SHL7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Sonic Healthcare is 909081. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Sonic Healthcare is SHL.AX. The ticker symbol is used to trade Sonic Healthcare shares on the stock exchange.

Over the past 12 months, Sonic Healthcare paid a dividend of 1.16 AUD . This corresponds to a dividend yield of about 5.16 %. For the coming 12 months, Sonic Healthcare is expected to pay a dividend of 1.36 AUD.

The current dividend yield of Sonic Healthcare is 5.16 %.

Sonic Healthcare pays a dividend, distributed in the months of , , , .

Sonic Healthcare paid dividends every year for the past 32 years.

For the upcoming 12 months, dividends amounting to 1.36 AUD are expected. This corresponds to a dividend yield of 6.04 %.

Sonic Healthcare is assigned to the 'Health' sector.

To receive the latest dividend of Sonic Healthcare from amounting to 0.57 AUD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Sonic Healthcare distributed 1.32 AUD as dividends.

The dividends of Sonic Healthcare are distributed in AUD.